In addition, we showed higher Hes1 expression in CD34 + cells from CLL patients compared to HD (4.2 ± 1.1 vs 1.1 ± 0.2) (Figure 1Diii), in line with upregulated NOTCH1 pathway. The gene discussed is HES1; the disease is B-cell chronic lymphocytic leukemia.